StockData
Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc. (RLAY) stock

RLAYNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$17.27−0.82 (-4.53%)

Close on Nov 16, 2026Market cap $3.78BP/E –Yield –

Relay Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Relay Therapeutics's total assets was $967.46M at Jun 30, 2026. For fiscal 2025 it was $621.33M, down 28.7% from the year before. The highest annual figure on record is $1.10B in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$621.33M-28.7%
FY2024Dec 31, 2024$871.30M+3.2%
FY2023Dec 31, 2023$843.98M-23.3%
FY2022Dec 31, 2022$1.10B+9.1%
FY2021Dec 31, 2021$1.01B+26.1%
FY2020Dec 31, 2020$799.83M+103.5%
FY2019Dec 31, 2019$393.07M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$967.46M+32.7%
Q1 FY2026Mar 31, 2026$699.61M-12.5%
Q4 FY2025Dec 31, 2025$621.33M-28.7%
Q3 FY2025Sep 30, 2025$670.00M-28.0%
Q2 FY2025Jun 30, 2025$728.84M-5.7%
Q1 FY2025Mar 31, 2025$799.36M-5.0%
Q4 FY2024Dec 31, 2024$871.30M+3.2%
Q3 FY2024Sep 30, 2024$930.12M+2.6%
Q2 FY2024Jun 30, 2024$772.55M-19.7%
Q1 FY2024Mar 31, 2024$841.44M-18.9%
Q4 FY2023Dec 31, 2023$843.98M-23.3%
Q3 FY2023Sep 30, 2023$906.96M-22.4%
Q2 FY2023Jun 30, 2023$962.02M+8.2%
Q1 FY2023Mar 31, 2023$1.04B+9.2%
Q4 FY2022Dec 31, 2022$1.10B+9.1%
Q3 FY2022Sep 30, 2022$1.17B+74.0%
Q2 FY2022Jun 30, 2022$889.42M+24.5%
Q1 FY2022Mar 31, 2022$949.88M+23.1%
Q4 FY2021Dec 31, 2021$1.01B+26.1%
Q3 FY2021Sep 30, 2021$671.62M-10.7%
Q2 FY2021Jun 30, 2021$714.40M+105.3%
Q1 FY2021Mar 31, 2021$771.35M+96.2%
Q4 FY2020Dec 31, 2020$799.83M–
Q3 FY2020Sep 30, 2020$751.68M–
Q2 FY2020Jun 30, 2020$348.04M–
Q4 FY2019Dec 31, 2019$393.07M–

More Relay Therapeutics figures

See a number that looks wrong?